HAP

(redirected from BAG1)
Also found in: Dictionary, Thesaurus, Medical, Legal.

HAP

[hap or ¦āch¦ā′pē]
(engineering)
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Tonges et al., "BAG1 promotes axonal outgrowth and regeneration in vivo via Raf-1 and reduction of ROCK activity," Brain, vol.
Real-time polymerase chain reaction (PCR) was employed to evaluate the relative mRNA expression level using the following primers: BAG1 forward: 5'-CAGGGCAGCAGTGAACCA-3', and reverse: 5'-ACCCGGCAACCATCTTGT-3'; BCL2 forward: 5'- CTGGGAGAACAGGGTACGATAA-3', and reverse: 5'-GGCTGGGAGGAGAAGATGC-3'; TP73 forward: 5'-CTCGGGAGGGACTTCAACG-3', and reverse: 5'-CCTGTGGTGGCTCATAGG-3'; CASP1 forward: 5'-ATTACAGACAAGGGTGCT-3', and reverse, 5'-GAATAACGGAGTCAATCAAA-3'; LTBR forward: 5'- CAAAGATGAAGTTGGGAAGG-3', and reverse: 5'- GTTTCCTGCAGAGAGAAGGGTGGCT-3'; CASP4 forward: 5'- GCACAATGGGCTCTATCT-3', and reverse: 5'-CAGTCGTTCTATGGTGGG-3'; GAPDH forward: 5'-AAGAGCACAAGAGGAAGAGAGAGAC-3', and reverse: 5'-GTCTACATGGCAACTGTGAGGAG-3'.
In addition, recombinant SAG1 and BAG1 antigens were used since these are typical antigens characterising the tachyzoite and bradyzoite stage of T.
miR-28-5p target Tumor type Reference p21 Choriocarcinoma cells [15] MPL Myeloproliferative neoplasms [16] N4BP1 Myeloproliferative neoplasms/ [9] ovarian cancer OTUB1 Myeloproliferative neoplasms [16] TEX-261 Myeloproliferative neoplasms [16] MAPK1 Myeloproliferative neoplasms [16] E2F6 Myeloproliferative neoplasms [16] MAD2L1 B-cell lymphomas [5] BAG1 B-cell lymphomas [5] RAP1B B-cell lymphomas/renal cell [3, 5] carcinoma
Schnieder et al., "BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease," Journal of Molecular Neuroscience, vol.
Conversely, interaction between the HSP70-HSP90 complex and the cochaperones BAG1 and CHIP, which can also act as an E3 ubiquitin ligase to catalyse the transfer of ubiquitin to the protein substrate, results in the inactivation of the HSPs ATPase folding activity, leading to client proteins being ubiquitinated and directed towards proteasomal degradation [206, 209].